PPT-A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K

δ Inhibitor Idelalisib GS1101 in Combination with Rituximab andor Bendamustine in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia CLL Coutre

Upload by windbey
Published on 2020-06-23

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/784608" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "A Phase 1 Study of the Selective Phospha..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.